• CMA levies fines of £2.3m in pharma probe pharmatimes
    July 10, 2020
    The UK's Competition and Markets Authority (CMA) has now formally concluded that three pharmaceutical companies - Aspen, Tiofarma, and Amilco - took part in an illegal arrangement that inflated the price of life-saving medicine fludrocortisone.
PharmaSources Customer Service